Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparing the Efficacy of Cumin Powder with Mebeverin in Irritable Bowel Syndrome
IRCT20171127037640N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of mebeverine in irritable bowel syndrome (IBS) (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Change in IBS severity score and Change in quality of life. Started Apr 2018; status: completed.
02
Drugs
mebeverine
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on IRCT20171127037640N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20171127037640N1.